Trials / Completed
CompletedNCT00311493
Evaluation of Long-Term Immunogenicity in Subjects Boosted With a TBE Vaccine for Adults
A Phase IV, Randomized, Open-Label, Multi-Center Study in Adults: Evaluation of Long-Term Immunogenicity in Subjects Boosted With a New TBE Vaccine for Adults (Free of Protein-Derived Stabilizer) in Study V48P2E1, 5 Years After First Booster Immunization and Evaluation of Booster Kinetics in Subjects Boosted With a New TBE Vaccine for Adults (Free of Protein-Derived Stabilizer), 5 Years After First Booster Immunization
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 179 (planned)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study it is to evalutate the persistence of antibodies after a booster immunisation with a TBE vaccine for adults
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Tick-Borne Encephalitis vaccine |
Timeline
- Start date
- 2006-02-01
- First posted
- 2006-04-06
- Last updated
- 2007-03-13
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00311493. Inclusion in this directory is not an endorsement.